Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

Sanofi entered a fresh round of exclusive negotiations to sell a controlling stake in its consumer health unit to Clayton ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...

The French government is seeking job guarantees from drugmaker Sanofi regarding its Doliprane production sites in the event ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

EDITORIAL. French pharmaceutical company Sanofi's plan to sell 50% of Opella, which produces France's favorite drug, to an ...

Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcare. Sanofi and CD&R enter exclusive negotiations to transfer a 50% controll ...